SEINE BIO · SCIENCE LIBRARY

Oxandrolone / Anavar

Anavar is a familiar name for oxandrolone, an oral anabolic steroid with historical catabolic-disease and burn research.

Hormone / related medicine

A closer look at the research, the uncertainties and the questions worth asking.

THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026

Inside the science of Oxandrolone / Anavar.

Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.

Compounding is appropriate only when lawful for the specific substance and patient; some substances may be unavailable. Finished FDA-approved medicines may also be dispensed by licensed non-compounding pharmacies.

Overview

Oxandrolone is an anabolic-androgenic steroid known by the name Anavar. It is not a peptide. Although it has a long medical literature, its current US regulatory history is important: FDA withdrew approval of Oxandrin in 2023 and subsequently determined that the product had been withdrawn for safety or effectiveness reasons.

Community Use

Fitness discussions often describe Anavar as a mild cutting product. That framing misses both its steroid pharmacology and the regulatory change. No matching profile was found in the requested peptide-community catalogs. This article examines clinical evidence and risks without providing a nonmedical course, cutting cycle, or instructions for sourcing it.

Doses, Durations & Cycles

Published dosing regimens. Product-label and study regimens for education, not instructions for self-treatment. Product, indication and route matter.

Protocol reference — Oxandrolone / Anavar
Route / formulation	Dose / reported phases	Frequency	Duration / break	Notes and source
Oral tablet	2.5–20 mg total daily, divided into 2–4 doses	Daily divided doses	Historical short course: 2–4 weeks Break: No bodybuilding break established	Historical U.S. prescribing information; approval withdrawn Archived oxandrolone label

Important context: FDA withdrew approval in 2023 and determined the products were withdrawn for safety or effectiveness reasons. The archived amounts are historical, not a current U.S. treatment option. Regulatory record.

Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.

Historical clinical amounts were used for defined medical conditions under monitoring. They are not a safe bodybuilding schedule, and an old label should not be presented as current prescribing authorization. The dosage section should identify the source’s date and status rather than reproduce a performance cycle or substitute a compounded product.

Research Findings

A randomized 2006 trial enrolled 81 adults with severe burns, studying hospital-related recovery outcomes. The population, acute injury setting, and co-interventions differ markedly from healthy users seeking definition or strength. It is human clinical research for severe illness, not evidence for a recreational program. Randomized severe-burn trial.

U.S. Approval & Access

FDA’s 2023 determination addresses Oxandrin tablets and their withdrawal for safety or effectiveness. Oxandrolone is also an anabolic steroid under controlled-substance rules. Historical use should not be confused with current FDA-approved fitness care or routine lawful compounding. FDA withdrawal determination.

What It Does in the Body

Oxandrolone’s anabolic effects arise from androgen-related activity; being an oral steroid does not separate muscle effects from other systemic actions. Mechanistic descriptions cannot show that an exposure is safe for a particular person or establish that a lower perceived androgenic effect eliminates liver or lipid concerns. Reliable onset, peak benefit, and duration for recreational physique use are not established by the severe-burn trial.

Benefits & Reported Experiences

The burn trial reported a hospital-stay benefit in its studied setting. It does not establish that a healthy person gains a safer physique or improves long-term health. When weighing evidence, consider disease severity and the outcome measured rather than lifting an anabolic result out of its treatment context.

Side Effects & Risks

Hepatic and lipid effects are important concerns in the clinical and regulatory record. Androgen-related reproductive effects also require attention. A normal appearance or absence of immediate symptoms cannot rule out changes detected through blood testing. Safety claims must acknowledge the withdrawal history rather than relying on older popularity.

Delivery Options

The historical product was an oral tablet. A research-vial listing or a differently formulated product is not equivalent to that preparation. This page offers no recreational dosing schedule, preparation guidance, or administration workaround. Changing the format cannot resolve the clinical or regulatory issues.

Product Quality & Storage

Current regulatory status must be reviewed before discussing supply. Counterfeit tablets and unverified formulations create additional risks, while an old product label cannot establish authenticity or lawful availability today. A licensed clinician should assess the condition and alternatives rather than treating access to a discontinued brand as the main goal. No current consumer storage directions are inferred from the discontinued brand; a historical label does not identify a lawful modern product.

Combinations & Interactions

No steroid stack or post-cycle plan is recommended. Additional hormones or ancillary drugs do not reverse the product’s approval history or establish a safe benefit-risk balance. An accurate history of prior use is more helpful to a clinician than an internet plan for managing each expected unwanted effect.

Talking With Your Provider

For muscle loss after illness, poor recovery, or hormone concerns, discuss the underlying diagnosis and established options. If you have already taken a product labeled Anavar, share its identity and any symptoms with your clinician. Care can address risks and next steps without judgment or a promise to continue the same substance.

Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.

Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.

Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.

Questions worth bringing to your appointment.

Are there alternatives that address my goal?
If treatment is appropriate, what monitoring and follow-up would I need?
Could my health history or current medicines change the risks?

Saved discussion topics 0

Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.

Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.

Explore your next step with SEINE BIO.

Bring your questions to a wellness consultation. Inclusion in this library does not indicate prescribing or product availability. A consultation does not guarantee a prescription.

Explore consultations Back to Hormones, anabolic steroids & related medicines

Educational information · U.S. context · October 7, 2026. No ordering, personalized dosing or injection instructions.

Bring your saved topics to your care team.

Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.

Choose saved topics for review →